The Plot Thickens: UnitedHealthcare was being investigated by the Department of Justice for antitrust violations and its CEO was accused of fraud before he was assassinated outside a Manhattan hotel on Wednesday.
Thompson, 50, was shot dead in what NYPD officials believe was a targeted attack as he exited the Hilton hotel before an investor conference. His killer remains on the loose.
Earlier this year the DoJ launched a probe into whether the nation's biggest insurer, led by Thompson, was unfairly restricting competitors and running a monopoly.
The DoJ also sued to block the company's acquisition of home health and hospice provider Amedisys, naming Thompson and others and accusing them of unlawful practices.
Thompson was accused of being aware of the DoJ probe into the company and not telling investors before he unloaded over 31 percent of his stock.
Last month, Simply Wall Street reported that amid the probe and lawsuit, UnitedHealth insiders had sold $16million of their stock - Thompson was the biggest insider seller, unloading $12million worth of shares, at about US$521 per share.
'We are challenging this merger because home health and hospice patients and their families experiencing some of the most difficult moments of their lives deserve affordable, high quality care options, said Attorney General Merrick B. Garland. 'The Justice Department will not hesitate to check unlawful consolidation and monopolization in the healthcare market that threatens to harm vulnerable patients, their families, and health care workers.'
READ | XPOST
Thompson, 50, was shot dead in what NYPD officials believe was a targeted attack as he exited the Hilton hotel before an investor conference. His killer remains on the loose.
Earlier this year the DoJ launched a probe into whether the nation's biggest insurer, led by Thompson, was unfairly restricting competitors and running a monopoly.
The DoJ also sued to block the company's acquisition of home health and hospice provider Amedisys, naming Thompson and others and accusing them of unlawful practices.
Thompson was accused of being aware of the DoJ probe into the company and not telling investors before he unloaded over 31 percent of his stock.
Last month, Simply Wall Street reported that amid the probe and lawsuit, UnitedHealth insiders had sold $16million of their stock - Thompson was the biggest insider seller, unloading $12million worth of shares, at about US$521 per share.
'We are challenging this merger because home health and hospice patients and their families experiencing some of the most difficult moments of their lives deserve affordable, high quality care options, said Attorney General Merrick B. Garland. 'The Justice Department will not hesitate to check unlawful consolidation and monopolization in the healthcare market that threatens to harm vulnerable patients, their families, and health care workers.'
READ | XPOST